Severe growth failure with primary insulin-like growth factor-1 deficiency - mecasermin - continuing authority application form (PB337)

Use this form to apply to continue PBS-subsidised treatment with mecasermin for severe growth failure with primary insulin-like growth factor-1 deficiency (IGFD).

Page last updated: 18 June 2024.
QC 63305